News Quantified

HALO – halozyme therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Halozyme granted injunction in Germany barring Merck's subcutaneous Keytruda [Seeking Alpha]

Halozyme Wins Preliminary Injunction Against Merck's Keytruda SC in Germany [Yahoo! Finance]

Halozyme Wins Preliminary Injunction Against Merck's Keytruda SC in Germany

Halozyme Therapeutics (NASDAQ:HALO) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $56.00 price target on the stock.

Halozyme Therapeutics, Inc. (HALO) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]

2.8%

BEAT

2.4%

BEAT

18.1%

BEAT

-0.2%

BEAT

Form 4 HALOZYME THERAPEUTICS, For: Dec 01 Filed by: Connaughton Bernadette

Form 4 HALOZYME THERAPEUTICS, For: Nov 26 Filed by: Torley Helen

Form 8-K HALOZYME THERAPEUTICS, For: Nov 18

Form S-8 HALOZYME THERAPEUTICS,

Form 4 HALOZYME THERAPEUTICS, For: Nov 10 Filed by: Torley Helen

Top News Gainers

11/12 Form 8-K/A HALOZYME THERAPEUTICS, For: Oct 30 21.4%

11/5 Halozyme Therapeutics, Inc. (NASDAQ: HALO) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $16.00 price target on the stock, down previously from $17.00. 10.6%

5/1 FDA OKs subcutaneous version of J&J's Darzalex [Seeking Alpha] 8.1%

3/20 Form DEFA14A HALOZYME THERAPEUTICS, 8.0%

1/9 Halozyme Therapeutics, Inc. (NASDAQ: HALO) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. 8.0%

4/3 Form 4 HALOZYME THERAPEUTICS, For: Apr 01 Filed by: Sun Elaine D 6.2%

1/14 Halozyme Provides 2020 Business Update And Financial Guidance 5.9%

1/8 Halozyme Therapeutics, Inc. (NASDAQ: HALO) is now covered by analysts at Goldman Sachs Group Inc. They set a "buy" rating on the stock. 5.4%

3/19 Form 4 HALOZYME THERAPEUTICS, For: Mar 19 Filed by: Kelley Kenneth J 4.5%

11/13 Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $400 Million of Convertible Senior Notes due 2024 4.5%

Top News Decliners

2/27 argenx SE (ARGX) Q4 2019 Earnings Call Transcript [The Motley Fool] -4.5%

4/3 Halozyme Announces Change Of Location Of Annual Stockholders' Meeting -4.4%

2/26 Halozyme Therapeutics To Present At The Cowen 40th Annual Health Care Conference -4.3%

5/13 Halozyme To Participate In Bank of America Merrill Lynch Health Care Conference 2019 -4.2%

8/8 Halozyme Therapeutics, Inc. (NASDAQ: HALO) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -3.9%

8/6 Halozyme Reports Second Quarter 2019 Results -3.2%

9/4 Form 8-K HALOZYME THERAPEUTICS, For: Sep 04 -3.2%

2/25 Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target lowered by analysts at JPMorgan Chase & Co. from $24.00 to $22.00. They now have an "overweight" rating on the stock. -3.0%

7/19 Halozyme Announces Janssen Submits Extension Application To European Medicines Agency For Subcutaneous Formulation Of DARZALEX® Utilizing ENHANZE® Technology -3.0%

7/3 Form SC 13D/A HALOZYME THERAPEUTICS Filed by: KIRK RANDAL J -2.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day